Skip to content

Author

R. Mahalingam

We have 2 of 56 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Colitis-Associated Colorectal Cancer—STAT3 Inhibition as a Preventive Strategy

Colorectal cancer (CRC) occurs with higher frequency in patients with inflammatory bowel disease (IBD) and has increased morbidity and mortality compared with CRC in patients in the general population. STAT3 has been implicated in CRC development, but strategies to target it have yet to be employed to prevent its occur...

Prema Robinson, Ho-Ang Tan, Zara Italia et al. · 0 citations
Open access Aug 2026

Malignant epithelial diversification and inflammatory neutrophil remodeling define a transitional stage between tumor cell dissemination and overt metastatic outgrowth in breast cancer

A transitional stage between tumor cell dissemination and overt metastatic outgrowth characterized by malignant epithelial diversification and inflammatory neutrophil remodeling is defined, providing a framework for investigating biomarkers and therapeutic vulnerabilities during this poorly accessible phase of metastat...

R. Pathania, Brian N. Papas, J. Kosak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.